WYMM Tour: Vancouver
Tuesday, April 8, 2025, 09:30 am–04:30 pm PST - Vancouver, British Columbia
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Tuesday, April 8, 2025, at the Morris J. Wosk Centre for Dialogue in Vancouver, British Columbia to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Register
Agenda
09:30 am–04:30 pm PST | Agenda (subject to change) | Speaker |
|---|---|---|
09:00 am–09:30 am | Registration/Breakfast | |
09:30 am–09:35 am | Welcome | Rosemary Sinclair Dokos, Oxford Nanopore Technologies |
09:35 am–10:00 am | Nanopore sequencing, the latest and greatest updates | Roger Bialy, Oxford Nanopore Technologies |
10:00 am–10:30 am | Clinical and research applications of Oxford Nanopore long-read sequencing | Danny E. Miller, University of Washington and Seattle Children’s Hospital |
10:30 am–11:00 am | Networking Break | |
11:00 am–11:30 am | Using Parent-of-Origin-Aware genomic analysis to enhance hereditary cancer care | Kasmintan Schrader, BC Cancer / University of British Columbia |
11:30 am–12:00 pm | Nanopore long-read sequencing of tumours from the Personalized Oncogenomics Program | Erin Pleasance, Genome Sciences Centre, BC Cancer |
12:00 pm–01:00 pm | Lunch | |
01:00 pm–01:30 pm | Details to follow | Karen Sherwood, Vancouver General Hospital / University of British Columbia |
01:30 pm–02:00 pm | From molecules to millions: scaling single-cell genomics and liquid biopsies in population cohorts for discovery and population health | Philip Awadalla, University of Oxford |
02:00 pm–02:15 pm | Networking Break | |
02:15 pm–02:45 pm | NanoVengers: Oxford Nanopore Technologies sequencing takes on antimicrobial resistant pathogens and vaccine development | Amy H Lee, Simon Fraser University / B.C. Children’s Hospital Research Institute |
02:45 pm–03:30 pm | Panel discussion | Rosemary Sinclair Dokos, Oxford Nanopore Technologies (Moderator) |
Speakers
)
Welcome
Rosemary Sinclair Dokos, Oxford Nanopore Technologies
...
)
Danny E.Miller, University of Washington and Seattle Children’s Hospital
...
)
Using Parent-of-Origin-Aware genomic analysis to enhance hereditary cancer care
Kasmintan Schrader, BC Cancer / University of British Columbia
Dr Schrader is a Medical Geneticist and Assistant Professor in the Department of Medical Genetics, U...
)
Nanopore long-read sequencing of tumours from the Personalized Oncogenomics Program
Erin Pleasance, Genome Sciences Centre, BC Cancer
Dr. Erin Pleasance is a Staff Scientist at the Michael Smith Genome Sciences Centre at BC Cancer. He...
Karen Sherwood, Vancouver General Hospital/University of British Columbia
...
)
NanoVengers: Oxford Nanopore Technologies sequencing takes on antimicrobial resistant pathogens and vaccine development
Amy H Lee, Simon Fraser University / B.C. Children’s Hospital Research Institute
Dr. Lee joined the Department of Molecular Biology and Biochemistry at Simon Fraser University as an...
)
From molecules to millions: scaling single-cell genomics and liquid biopsies in population cohorts for discovery and population health
Philip Awadalla, University of Oxford
Dr. Philip Awadalla, is a Professor of Molecular Genetics at the University of Oxford, Big Data Inst...